Alireza shokrgozar; yasamin nekoonam; Farkhondeh Nikkhah
Abstract
anxiety in people with coronary artery disease. Method: The statistical population of the present study was all patients referred to counseling and psychology centers in Tehran Region 5 in 2020. In the present study, 18 people were randomly selected from Nedaye Daroon Psychological Counseling Center ...
Read More
anxiety in people with coronary artery disease. Method: The statistical population of the present study was all patients referred to counseling and psychology centers in Tehran Region 5 in 2020. In the present study, 18 people were randomly selected from Nedaye Daroon Psychological Counseling Center and placed in two experimental and control groups. Participants were assessed using the Petersburg (1989) Beck Anxiety Inventory (1988) Sleep Quality Scale. The participants in the experimental group were then treated with neurofeedback for 15 one-hour sessions and the control group did not receive any training. Data were analyzed using analysis of covariance. Results: The results showed that the differences between the control and experimental groups were effective in the components of sleep quality, sleep disorders, sleeping pills, and daily dysfunction. In other words, neurofeedback therapy reduced the scores of these components, but this treatment had an effect on other components. Was not significant and also the number of anxiety scores in the post-test of the experimental group decreased significantly. Conclusion: Considering the effectiveness of neurofeedback therapy on increasing the quality of sleep and reducing anxiety in individuals, this treatment can be used in the form of treatment programs in coronary conditions.
Mohammad Oraki; Afsaneh Dortaj; Atousa Mehdizadeh
Volume 2, Issue 6 , December 2016, , Pages 45-60
Abstract
Introduction: The aim of this study was to investigate the effectiveness of neurofeedback treatment on depression, anxiety, stress and psychosomatic abdominal pains in patients with clinical chronic psychosomatic abdominal pains in Shiraz. Methods: This research was a quasi-experimental study with pretest-posttest ...
Read More
Introduction: The aim of this study was to investigate the effectiveness of neurofeedback treatment on depression, anxiety, stress and psychosomatic abdominal pains in patients with clinical chronic psychosomatic abdominal pains in Shiraz. Methods: This research was a quasi-experimental study with pretest-posttest control group. The study population was all women with chronic psychosomatic abdominal pains among whom, 40 patients were selected for this study; ultimately, data were analyzed with 30 patients (experimental group=15 and control group=15). Participants were randomly assigned to 2 groups consisting of 15 participants who were divided into an experimental group and a control group. In this intervention, the experimental group was treated with neurofeedback for 10 weeks (3 times a week for 40 minutes) and the control group received no intervention and was put on a waiting list. Also, experimental and control groups completed the Depression Anxiety Stress Scales-21 (DASS-21) in pre-test and post-test. Multivariate analysis of covariance was used for data analysis. Findings: The results of covariance analysis showed that neurofeedback therapy had an impact on reducing anxiety and depression (P<0.001). In other words, 53% of depression variation and 57% of anxiety variation in patients were due to neurofeedback, but neurofeedback revealed no effect on stress. Conclusion: It was concluded that neurofeedback could significantly reduce depression and anxiety, but it had no effect on stress.
Seyed Younes Mohammadi; Taeaba Malmir; Mitra Golzari
Volume 2, Issue 5 , September 2016, , Pages 71-82
Abstract
Introduction: The aim of this study was to investigate the impact of neurofeedback treatment on assertiveness and anxiety of panic attack sufferers. Methods: This study due to its goals and assumptions is quasi-experimental. A pretest-posttest control/experimental group design was used. 20 people ...
Read More
Introduction: The aim of this study was to investigate the impact of neurofeedback treatment on assertiveness and anxiety of panic attack sufferers. Methods: This study due to its goals and assumptions is quasi-experimental. A pretest-posttest control/experimental group design was used. 20 people who refered to counseling and treatment centers and psychiatric clinics were selected in Tehran in 1395 through random sampling from patients who were diagnosed by physiatrists as having panic. Participants were divided into two groups of 10 patients. The experimental group received 20 sessions of neurofeedback treatment (45 minutes). The control group received no intervention. The two groups received Beck Anxiety Inventory questionnaire to determine the level of anxiety and Gambrill and Ridgecrest to evaluate their self-expression in both pretest and posttest. To analyze the data variance analysis and multivariate analysis of variance were used. Findigs: The results show that neurofeedback treatment, have significant effects on reducing anxiety and increasing assertiveness in patients with panic attack disorder (PConclusion: neurofeedback treatment is effective in reducing anxiety and increasing assertiveness of patients with panic disorder.
